Drug Pricing and Affordable Insulin Issues Take Precedence

Action on drug pricing and access to affordable insulin has heated up in Congress as part of the consideration of a large budget reconciliation process. The Endocrine Society has been a leading advocate urging the Biden Administration and Congress to take action on drug pricing and has offered several policy recommendations, including allowing the government...

Endocrine Society Shares ARPA-H Priorities

On August 3, Endocrine Society President Carol Wysham, MD, shared the Society’s recommendations and concerns about the proposal for a new federal agency, the Advanced Research Projects Agency for Health (ARPA-H) as part of a listening session with National Institutes of Health (NIH) Director Francis Collins. Wysham highlighted diabetes as a prime example of a...

Grants Available for Early-Career Scientists Focusing on Type 1 Diabetes

Diabetes Research Connection announces grants ranging from $25,000 to $50,000 for early-career scientists focused on type 1 diabetes research from those seeing funding for research aimed at finding a cure, prevention, and treatments.   Diabetes Research Connection (DRC), a 501(c)(3) that connects early-career scientists and donors to fund research projects aimed at prevention, cure, and better care...

Endocrine Society Discusses ARPA-H with Congress, NIH, and OSTP

When President Joe Biden’s budget for fiscal year 2022 was introduced this summer, many biomedical research advocates took note of a new line item that would direct $6.5 billion over three years to a new Advanced Research Projects Agency for Health (ARPA-H) to be housed at the National Institutes of Health (NIH). While we were...

Endocrine Society Participates in European Union Activity to Advise on Implementation of its Chemical Strategy

The Endocrine Society achieved a major victory in the new European Union (EU) Chemicals Strategy for Sustainability (CSS) by including several priority actions on endocrine-disrupting chemicals (EDCs) within the strategy. The CSS commits the EU towards a series of actions to better protect citizens and the environment and promote innovation in safe and sustainable chemicals....

Endocrinology Advocacy

Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.

Important Advocacy Information From the Endocrine Society

As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.

Both Clinical and Research Advocacy Information

On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.